PLx Pharma Inc.
(NASDAQ) PLXP
PLx Pharma Inc. Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$4.54M
Net Income (TTM)
$15.14M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
PLXP News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout PLx Pharma Inc.
Industry
Pharmaceuticals
Sector
Health CareEmployees
19
CEO
Natasha Giordano
Website
www.plxpharma.comHeadquarters
Sparta, NJ 07871, US
PLXP Financials
Key Financial Metrics (TTM)
Gross Margin
41%
Operating Margin
-5%
Net Income Margin
-6%
Return on Equity
-2%
Return on Capital
-63%
Return on Assets
-67%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$3.40M
Operating Income
$40.79M
EBITDA
$35.24M
Operating Cash Flow
$32.12M
Capital Expenditure
$0.00
Free Cash Flow
$32.12M
Cash & ST Invst.
$69.39M
Total Debt
$0.00
PLx Pharma Inc. Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$386.00K
-94.2%
Gross Profit
$1.07M
-139.7%
Gross Margin
-2.78%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
16
N/A
Net Income
$6.16M
+71.6%
EBITDA
$13.00M
+39.7%
Quarterly Fundamentals
Net Cash
$25.83M
-68.7%
Accounts Receivable
$139.00K
-95.7%
Inventory
$3.18M
+45.1%
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-67.14%
N/A
Return on Invested Capital
-62.98%
N/A
Free Cash Flow
$10.98M
-22.1%
Operating Cash Flow
$10.98M
-22.1%